Transgender patients may have increased risk of cardiovascular diseases
According to a study presented at the American Heart Association Scientific Sessions 2020, transgender patients undergoing gender-affirming hormone therapy may have an increased risk of cardiovascular diseases.The Cardiology Advisor (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 9, 2020 Category: Endocrinology Source Type: news
Breast Cancer Surgery Feasible for Most Fit Older Women
Hormone therapy alone may be as good as surgery if life expectancy is less than four years (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 23, 2020 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Surgery, Geriatrics, Conference News, Source Type: news
Advanced prostate cancer has an unexpected weakness that can be targeted by drugs
(Kanazawa University) Kanazawa University researchers reported that the SUCLA2 gene is frequently involved in the deletion of the tumor suppressor gene RB1 in advanced prostate cancer. RB1 deletion makes cells resistant to hormone therapy but SUCLA2 deletion induces a metabolic weakness. The study showed that thymoquinone selectively killed SUCLA2-deficient prostate cancer cellsinvitro andinvivo. The findings highlight a vulnerability of advanced prostate cancer cells that can be targeted by drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 7, 2020 Category: Cancer & Oncology Source Type: news
Scientists discover potential new treatment for breast cancer
A team of Irish scientists may have discovered a potential new treatment option for patients with breast cancer who are resistant to hormone therapy, according to a study published in the journalCancer Research.Independent.ie (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 5, 2020 Category: Endocrinology Source Type: news
Judgment Free Online Platform Key to Helping Suicidal People, Says Survivor
A suicide survivor shares her story of how an online community helped her overcome anxiety and depression. Credit: Unsplash / Dan M By Fairuz AhmedNEW YORK, Sep 28 2020 (IPS) Romana Hoque had it all, a comfortable life, a happy family. Despite this, the 43-year-old second-generation immigrant from Indonesia living in the United States was depressed enough to contemplate suicide.
Hoque, in an exclusive interview with Inter Press Service (IPS), said despite her comfortable life, not being able to conceive resulted in her feeling so depressed that she tried to take her own life. She shared her story during September – set ...
Source: IPS Inter Press Service - Health - September 28, 2020 Category: International Medicine & Public Health Authors: Fairuz Ahmed Tags: Aid Featured Gender Global Headlines Health TerraViva United Nations Fuzia 2020 Source Type: news
New hormone therapies for hot flashes offer enhanced benefits and minimized risk
(The North American Menopause Society (NAMS)) Hormone therapy remains the best proven method for managing menopause symptoms such as hot flashes. Research continues, however, in the area to identify novel approaches to estrogen therapy that minimize any associated risks. Dr. Hugh Taylor from Yale School of Medicine will discuss some of the latest developments, including fetal estrogens, during the 2020 Pre-Meeting Symposium of The North American Menopause Society (NAMS). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 28, 2020 Category: Cancer & Oncology Source Type: news
How hormone therapy slows progression of atherosclerosis
(The North American Menopause Society (NAMS)) As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis. A study based on Early Versus Late Intervention Trial With Estradiol (ELITE) data evaluated the underlying mechanism of such benefit and will be presented during the 2020 Virtual Annual Meeting of The North American Menopause Society (NAMS), opening on September 28. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 28, 2020 Category: International Medicine & Public Health Source Type: news
First new drug in years reduces recurrence in high risk HR+ early breast cancer
(European Society for Medical Oncology) Lugano, Switzerland, 20 September 2020 - Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2020 Category: International Medicine & Public Health Source Type: news
PARPi olaparib for the targeted treatment of metastatic prostate cancer
(Vall d'Hebron Institute of Oncology) Results from the PROfound phase III study open up a new treatment avenue for the more precise and effective treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed with hormonal therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2020 Category: International Medicine & Public Health Source Type: news
Factors Tied to Hormone Therapy Use After Oophorectomy ID'd
MONDAY, Aug. 17, 2020 -- Age at surgery, education level, and preventive mastectomy are associated with hormone therapy (HT) use after preventive oophorectomy in BRCA mutation carriers, according to a study published online Aug. 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2020 Category: Pharmaceuticals Source Type: news
Delaying prostate cancer radiation therapy offers room for flexibility in pandemic peak
(Brigham and Women's Hospital) A new study by investigators from Brigham and Women's Hospital found that for men with unfavorable intermediate-risk or high-risk localized prostate cancer, who are receiving radiation and hormone therapy, delaying radiation while remaining on hormone therapy is unlikely to impact survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 13, 2020 Category: Cancer & Oncology Source Type: news
Age, education, and surgical history affect hormone use after oophorectomy
(The North American Menopause Society (NAMS)) CLEVELAND, Ohio (August 12, 2020)--Removal of the ovaries before natural menopause (surgical menopause) often exacerbates menopause symptoms and places women at increased risk for heart disease, osteoporosis, and cognitive decline. A new study identified the frequency of hormone therapy (HT) use and factors that determine who is more likely to use hormones after oophorectomy to manage symptoms. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 12, 2020 Category: Cancer & Oncology Source Type: news
Testicular Seminoma During Transgender Woman Hormone Therapy Testicular Seminoma During Transgender Woman Hormone Therapy
Gender-affirming hormone therapy unmasked an unsuspected hCG-secreting testicular seminoma in a transgender woman. How was this case diagnosed?Journal of the Endocrine Society (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 4, 2020 Category: Radiology Tags: Diabetes & Endocrinology Journal Article Source Type: news
Studies suggest a fasting diet could boost breast cancer therapy
(University of Southern California) A USC-led team of scientists has found that a fasting-mimicking diet combined with hormone therapy has the potential to help treat breast cancer, according to newly published animal studies and small clinical trials in humans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2020 Category: International Medicine & Public Health Source Type: news
Women taking menopausal hormone therapy may be more resistant to urine infections
(European Association of Urology) In the first analysis of its kind, US-based doctors have shown that women who take menopausal hormone therapy (MHT, also known as HRT) have a greater variety of beneficial bacteria in their urine, possibly creating conditions that discourage urinary infections. The study also shows that women who suffer from recurrent urine infections have fewer different types of bacteria in urine than women who don't have infections, making them more prone to infections. Presented at the European Association of Urology Virtual Congress (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 17, 2020 Category: International Medicine & Public Health Source Type: news
